A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.

Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.

Broad-acting antibiotics can disrupt the gut microbiome and create the perfect conditions for potentially life-threatening yeast infections to flourish.

A protein in cilia called CFAP53 is responsible for the distinct beat patterns during embryonic development, researchers say.

Induced pluripotent stem cells have helped researchers map the role of the RFX6 gene in a rare congenital disorder known as Mitchell-Riley Syndrome.

Asian patients with suspected but undiagnosed rare genetic diseases could get answers sooner thanks to next-generation sequencing technologies.

Scientists identify a key molecular marker of muscle stem cells, providing novel insights into the mechanisms around muscle regeneration.

A novel 3D printing method developed by A*STAR researchers fabricates soft support for tissue growth, with embedded channels that ensure nutrient supply.

A scalable cell culture platform can generate universal red blood cells from stem cells, paving the way for manufacturing an abundant supply of blood for transfusions.

In COVID-19 long-haulers, an unrelenting immune response damages blood vessels, making them more susceptible to developing blood clots.

Scientists have identified a network of neurons that drives overeating in response to environmental cues, rather than genuine hunger.

From expanding the genetic alphabet to uncovering antibiotics hidden in silent genes, A*STAR’s researchers are wielding the tools of synthetic biology to improve our lives in surprising ways.